STOCK TITAN

Form 144 and 10b5-1 sales reported for KYMR (NASDAQ: KYMR)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Form 144 filed reporting a proposed sale of 14,640 shares of Common Stock. The filing lists the sale as an Exercise of Stock Options with proceeds shown and a trade date of 04/01/2026. The submission also lists multiple prior 10b5-1 sales by Jeremy Chadwick in March 2026, including 91,250 shares on 03/23/2026 and 24,727 shares on 03/25/2026.

Positive

  • None.

Negative

  • None.
Proposed sale 14,640 shares Exercise of Stock Options dated 04/01/2026
10b5-1 sale 91,250 shares Sale on 03/23/2026 by Jeremy Chadwick
10b5-1 sale 24,727 shares Sale on 03/25/2026 by Jeremy Chadwick
10b5-1 sale 7,600 shares Sale on 03/31/2026 by Jeremy Chadwick
Proceeds (example) $7,063,733.26 Proceeds shown for 91,250-share sale on 03/23/2026
Proceeds (example) $1,984,554.44 Proceeds shown for 24,727-share sale on 03/25/2026
10b5-1 regulatory
"10b5-1 Sales for JEREMY CHADWICK 500 North Beacon Street"
A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.
Exercise of Stock Options financial
"Common | 04/01/2026 | Exercise of Stock Options | Issuer"
Form 144 regulatory
"144: Securities To Be Sold"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does KYMR's Form 144 report?

It reports a proposed sale of 14,640 shares via exercise of stock options dated 04/01/2026. The filing also lists prior 10b5-1 sales by Jeremy Chadwick in March 2026, with specific trade dates and share counts included.

Who appears as the selling party in the KYMR Form 144?

The filing lists Jeremy Chadwick in connection with multiple 10b5-1 sales during March 2026. A broker entry for Morgan Stanley Smith Barney LLC is shown for the 14,640-share transaction dated 04/01/2026.

How many shares were sold under the 10b5-1 trades listed?

The excerpt lists several 10b5-1 transactions, for example 91,250 shares on 03/23/2026 and 7,600 shares on 03/31/2026. Each entry shows trade dates, share counts, and dollar proceeds for those sales.

Does the Form 144 indicate proceeds for the proposed sale?

Yes; the 14,640-share line shows a proceeds figure associated with the transaction dated 04/01/2026. Several prior March sales also display gross proceeds alongside share counts and dates.

Are the March 2026 10b5-1 sales separate from the 04/01/2026 transaction?

Yes; the filing lists multiple March 2026 10b5-1 sales by Jeremy Chadwick on distinct dates and a separate 14,640-share entry dated 04/01/2026 described as an exercise of stock options.